Stocks To Buy Now

Blog


Monaker Group, Inc. (MKGI) Engages DreamTeamNetwork’s Corporate Communications Service Suite

Monaker Group, Inc. (OTCQB: MKGI), a technology-driven travel company, today announced that it has engaged corporate communications firm DreamTeamNetwork (“DTN”). Austin, Texas-based DTN has helped more than 300 public companies fine tune their corporate communications strategies, which include investor relations, public relations, and social media relations, as well as branding and marketing, video production and website development.

“As we continue to advance our business model and dig our heels into key niches of the travel industry, communication with our shareholders has never been more important,” says Monaker Chairman and Chief Executive Officer Bill Kerby. “By partnering with DTN we have the opportunity to focus on both short and long-term corporate initiatives while strengthening our corporate message.”

Per the agreement, DTN will leverage its family of unique brands, along with an extensive network of partners, daily and weekly newsletters, social media channels, blog and other outreach tools, to further develop Monaker’s brand awareness and communication with shareholders.

“Monaker is rapidly gaining traction in the alternative lodging industry. With a visionary management team and unique booking engine, Monaker has potential for incredible growth in an increasingly lucrative market,” stated Michael McCarthy, Managing Director for DTN. “As a trusted partner, DTN looks forward to assisting the company with its transparency and communication with existing shareholders and the broader investment community.”

For more information, visit www.monakergroup.com

Let us hear your thoughts: Monaker Group, Inc. Message Board

From Our Blog

HeartBeam Inc. (NASDAQ: BEAT) Highlighted Among Medical Device Innovators as FDA Clearances Set Tone for New Year

February 12, 2026

HeartBeam (NASDAQ: BEAT) was recently recognized among a select group of medical device companies featured in a January industry roundup highlighting recent U.S. Food and Drug Administration (“FDA”) clearances and approvals across the sector. The recognition underscores HeartBeam’s progress as it advances a novel approach to cardiac diagnostics through its HeartBeam System, a cable-free, high-fidelity […]

Rotate your device 90° to view site.